TAGRISSO is a registered trademark of the AstraZeneca group of companies. ©2018 AstraZeneca. All rights reserved. US-16058 5/18
Tell your doctor about all the medicines you take, including prescription
and over-the-counter medicines, vitamins, or herbal supplements.
Especially tell your doctor if you take a heart or blood
The most common side effects of TAGRISSO are:
• diarrhea • mouth sores
• rash • tiredness
• dry skin • decreased appetite
• changes in your nails, including: redness, tenderness, pain, inflammation,
brittleness, separation from nailbed, and shedding of nails
Tell your doctor if you have any side effect that bothers you or that
does not go away.
These are not all the possible side effects of TAGRISSO. For more
information, ask your doctor or pharmacist.
Call your doctor for medical advice about side effects.
You are encouraged to report negative side effects of prescription drugs
to the FDA. Visit www.FDA.gov/medwatch or call 1-800-FDA-1088.
What is TAGRISSO?
TAGRISSO is a prescription medicine for non-small cell lung cancer
(NSCLC) that has spread to other parts of the body (metastatic).
TAGRISSO is used:
• as a first treatment if tumors have a certain abnormal epidermal
growth factor receptor (EGFR) gene(s)
• for a certain type of EGFR gene that has been treated with an EGFR
tyrosine kinase inhibitor (TKI) medicine that did not work or is no
Your doctor will perform a test to make sure that TAGRISSO is right for you.
It is not known if TAGRISSO is safe and effective in children.
Please see Brief Summary of Prescribing Information on following page.
If you can’t afford your medication, AstraZeneca may be able to help.
Learn more at